Anti-tumour immunity was observed against B16 tumours expressing either constitutive or IFNγ inducible HLA-DP*0401 suggesting that the CD4 T cell response may exert both direct and indirect effects upon the tumour to promote inflammation and MHCII upregulation. The gene discussed is CD4; the disease is neoplasm.